연구성과로 돌아가기

2025 연구성과별 연구자 정보 (142 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Mun, Myeong-Hwan Mun, MH 1 교신저자 Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Mun, Myeong-Hwan Mun, MH 1 교신저자 Soongsil Univ, Dept Phys, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Mun, Myeong-Hwan Mun, MH 1 교신저자 Soongsil Univ, Origin Matter & Evolut Galaxies OMEG Inst, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Heo, Kyoungsu Heo, K 2 Soongsil Univ, Dept Phys, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Heo, Kyoungsu Heo, K 2 Soongsil Univ, Origin Matter & Evolut Galaxies OMEG Inst, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Cheoun, Myung-Ki Cheoun, MK 3 Soongsil Univ, Dept Phys, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Calculation of α Decay Half-Lives for Tl, Bi, and At Isotopes Cheoun, Myung-Ki Cheoun, MK 3 Soongsil Univ, Origin Matter & Evolut Galaxies OMEG Inst, Seoul 06978, South Korea aa3101@gmail.com; pleasewhy@naver.com; cheoun@ssu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Jung, Sung-Koog Jung, SK 1 Kyungpook Natl Univ, Sch Dent, Dept Oral Physiol, Daegu 41940, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Kim, Yu-Mi Kim, YM 2 Kyungpook Natl Univ, Sch Dent, Dept Oral Physiol, Daegu 41940, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Jo, Min-Jeong Jo, MJ 3 Kyungpook Natl Univ, Sch Dent, Dept Oral Physiol, Daegu 41940, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Son, Jo-Young Son, JY 4 Kyungpook Natl Univ, Sch Dent, Dept Oral Physiol, Daegu 41940, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Ju, Jin-Sook Ju, JS 5 Kyungpook Natl Univ, Sch Dent, Dept Oral Physiol, Daegu 41940, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Park, Min-Kyoung Park, MK 6 Kyung Woon Univ, Dept Dent Hyg, Gumi 39160, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Lee, Min-Kyung Lee, MK 7 Dong Eui Univ, Dept Dent Hyg, Busan 47340, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Kim, Jae-Young Kim, JY 8 JETEMA, Global 225-12, Seongnam 13494, South Korea ln3000@hanmail.net; boboatom@naver.com; dmvvv3@naver.com; n-violetjy@nate.com; jsju@knu.ac.kr; bukimin@hanmail.net; lmk849@deu.ac.kr; jykim@jetema.com; jsnam@jetema.com; dkahn@knu.ac.kr;
페이지 이동: